What does RBM mean to Sanofi's CRAs and site monitors

July 16, 2013

Applied Clinical Trials

Lori Convy, Assistant Director, Clinical Research Monitoring, Sanofi discusses what risk-based monitoring mean to Sanofi's CRAs and site monitors?


Related Content:

Risk-Based Monitoring